Quintana Theresa A, Brewer Matthew T, Jesudoss Chelladurai Jeba R J
Department of Diagnostic Medicine and Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS, USA; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL, USA.
Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, Ames, IA, USA.
Int J Parasitol Drugs Drug Resist. 2025 Sep 19;29:100614. doi: 10.1016/j.ijpddr.2025.100614.
Toxocara canis, the causative agent of zoonotic toxocariasis in humans, is a parasitic roundworm of canids with a complex life cycle. While macrocyclic lactones (MLs) are successful at treating adult T. canis infections when used at FDA-approved doses in dogs, they fail to kill somatic third-stage larvae. In this study, we profiled the transcriptome of third-stage larvae derived from larvated eggs and treated in vitro with 10 μM of the MLs ivermectin and moxidectin. We analyzed transcriptional changes in comparison with untreated control larvae. In ivermectin-treated larvae, we identified 608 differentially expressed genes (DEGs), of which 453 were upregulated and 155 were downregulated. In moxidectin-treated larvae, we identified 1413 DEGs, of which 902 were upregulated and 511 were downregulated. Notably, many DEGs were involved in critical biological processes and pathways including transcriptional regulation, energy metabolism, body structure and function, physiological processes such as reproduction, excretory/secretory molecule production, host-parasite response mechanisms, and parasite elimination. We also assessed the expression of known ML targets and transporters, including glutamate-gated chloride channels (GluCls), and ATP-binding cassette (ABC) transporters, subfamily B, with a particular focus on P-glycoproteins (P-gps). We present gene names for previously uncharacterized T. canis GluCl and transporter genes using phylogenetic analysis of nematode orthologs to provide uniform gene nomenclature. Our study revealed that the expression of two GluCls and eight ABCB genes, particularly five P-gps were significantly altered in response to ML treatment. Compared to controls, Tca-glc-3, Tca-avr-14, Tca-haf-10, and Tca-Pgp-13.2 were downregulated in ivermectin-treated larvae, while Tca-abcb7, Tca-Pgp-11.2, and Tca-Pgp-2 were downregulated in moxidectin-treated larvae. Conversely, Tca-haf-9, Tca-Pgp-11.3, and Tca-Pgp-16.3 were upregulated in moxidectin-treated larvae. These findings suggest that MLs broadly impact transcriptional regulation in T. canis larvae.
犬弓首蛔虫是人类人畜共患弓首蛔虫病的病原体,是一种寄生于犬科动物的线虫,其生命周期复杂。虽然大环内酯类药物(MLs)在以美国食品药品监督管理局(FDA)批准的剂量用于犬类治疗成年犬弓首蛔虫感染时很成功,但它们无法杀死体细胞第三期幼虫。在本研究中,我们分析了来自含幼虫卵并在体外经10μM MLs伊维菌素和莫西菌素处理的第三期幼虫的转录组。我们分析了与未处理的对照幼虫相比的转录变化。在经伊维菌素处理的幼虫中,我们鉴定出608个差异表达基因(DEGs),其中453个上调,155个下调。在经莫西菌素处理的幼虫中,我们鉴定出1413个DEGs,其中902个上调,511个下调。值得注意的是,许多DEGs参与了关键的生物学过程和途径,包括转录调控、能量代谢、身体结构和功能、生殖等生理过程、排泄/分泌分子产生、宿主-寄生虫反应机制以及寄生虫清除。我们还评估了已知的ML靶点和转运蛋白的表达,包括谷氨酸门控氯离子通道(GluCls)和ATP结合盒(ABC)转运蛋白B亚家族,特别关注P-糖蛋白(P-gps)。我们利用线虫直系同源物的系统发育分析为以前未鉴定的犬弓首蛔虫GluCl和转运蛋白基因提供基因名称,以提供统一的基因命名法。我们的研究表明,两种GluCls和八个ABCB基因,特别是五个P-gps的表达在ML处理后发生了显著变化。与对照组相比,在经伊维菌素处理的幼虫中,Tca-glc-3、Tca-avr-14、Tca-haf-10和Tca-Pgp-13.2下调,而在经莫西菌素处理的幼虫中,Tca-abcb7、Tca-Pgp-11.2和Tca-Pgp-2下调。相反,在经莫西菌素处理的幼虫中,Tca-haf-9、Tca-Pgp-11.3和Tca-Pgp-16.3上调。这些发现表明MLs广泛影响犬弓首蛔虫幼虫的转录调控。